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Introduction 
Silk has fascinated humans since ancient times; silk fibres have been used in textiles for more 
than 5,000 years and for many centuries as a suturing material (Lubec, Holbaubek et al. 1993, 
Omenetto and Kaplan 2010). The remarkable strength and toughness of silk stems from its 
evolution as a structural engineering material in nature (Vollrath and Porter 2009, Buehler 2013).  
 
Silk is a sustainable and ecologically benign biopolymer that can be manufactured using 
green processes (Vollrath and Porter 2009). Over the past 25 years, we have seen a tremendous 
development of both bottom-up and top-down approaches for the generation of silk biopolymers. 
Specifically, reverse engineering of silk cocoons and the advent of recombinant technologies 
have been paramount for a better understanding of silks (Chung, Kim et al. 2012, Tokareva, 
Jacobsen et al. 2014). For example, molecular simulation studies (Buehler 2013), coupled with 
dedicated mechanical testing of recombinant and natural silks (Vollrath and Porter 2009), have 
increased our appreciation of the critical importance of silkÕs hierarchal structure by which it 
serves its function (e.g. protects the developing moth in the silk cocoons and catches spiderÕs prey 
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in orb-webs) (Omenetto and Kaplan 2010). Thus, natural silk fibres can serve as blueprints for 
novel designer polymers.  
 
Today, silkÕs remarkable physical properties have supported high-end applications, 
including its use in bulletproof vests (Gatesy, Hayashi et al. 2001), parachute cords (Kluge, 
Rabotyagova et al. 2008), composite materials for the aviation industry (Hardy and Scheibel 
2009), photonics (Omenetto and Kaplan 2008) and electronics (Kim, Viventi et al. 2010). The 
medical use of silk dates back to its use as a suture material; here the unique physical properties, 
handling and biocompatibility of silk fibres have been critical for its continued success, as well as 
for its approval by the Food and Drug Administration (FDA) as a biopolymer for use in humans. 
However, the medical applications of silk that have emerged over the past decade go beyond its 
traditional load-bearing applications (Altman, Diaz et al. 2003, Omenetto and Kaplan 2010). In 
this chapter, we examine the role of silk in drug and cell delivery applications, with specific 
reference to silk hydrogels, and we highlight emerging trends, opportunities and challenges, as 
well as provide a sound background on silk biopolymers for the silk novice. 
 
Silk Structure-Function Relationships 
For the purpose of this chapter, we use the term silk to refer to protein-based fibre-forming 
materials spun by living organisms. Spiders and silkworms are the most prominent organisms 
associated with silk production, although silks are made by many arthropod taxa (Vollrath and 
Porter 2009, Porter, Guan et al. 2013). Furthermore, spiders make more than one type of silk. For 
example, the common European garden spider, Araneus diadematusor, and the golden silk spider, 
Nephila clavipes, spin seven different silks from seven sets of different silk glands (Vollrath 
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1992); these silks are often used in combination simultaneously to fine tune the overall fibre 
composition and subsequent performance. Nonetheless, the silks used for drug delivery 
applications are typically those produced by the silkworm, Bombyx mori, or recombinant versions 
of spider silks (Yucel, Lovett et al. 2014). Where appropriate, we distinguish between silkworm 
silk (fibroin) from the cocoons of B. mori and spider silks. We also differentiate silk materials 
that are reverse engineered native proteins from those generated in heterologous hosts via genetic 
engineering. When not specifically stated, we refer to silkworm silk because B. mori silk is most 
commonly used due to its abundance (Seib and Kaplan 2013). The hierarchal structure of silk 
enables this biopolymer to serve specific functions (Fig. 1a, b), including tailored drug release 
and payload protection. The following section details silk structure with specific reference to drug 
delivery. 
Bombyx mori Silk 
The B. mori silk heavy chain consists predominantly of five amino acids: 45.9% glycine (G), 
30.3% alanine (A), 12.1% serine (S), 5.3% tyrosine (Y), and 1.8% valine (V) and only 4.6% of 
the other 15 amino acid types (Zhou, Confalonieri et al. 2001). B. mori silk is a very large (2.3 
MDa) protein that is made up of a heavy chain (approximately 350 kDa) (Zhou, Confalonieri et 
al. 2000)  and a light chain (approximately 26kDa) (Yamaguchi, Kikuchi et al. 1989)  that are 
held together by a single disulphide bond at the C terminus (Tanaka, Kajiyama et al. 1999) (Fig. 
1b); this disulphide linkage is critically important for the successful secretion of silk from the silk 
gland. The 2.3 MDa elementary silk unit is composed of six sets of disulphide-linked heavy and 
light chain heterodimers that assemble and are physically complexed by one molecule of 
fibrihexamerin (P25, approximately 25kDa). Fibrihexamerin has N-linked high mannose type 
oligosaccharide chains that facilitate the physical interaction with the silk heavy chain (Inoue, 
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Tanaka et al. 2000, Inoue, Tanaka et al. 2004). The 6:6:1 molar ratio of heavy chain, light chain 
and fibrihexamerin that makes up the silk elementary unit ensures solubility during transport, 
both intracellularly and in the silk gland (Zhou, Confalonieri et al. 2001). However, the heavy 
chain is of particular importance for the overall physical performance of silk and is believed to 
have a critical influence on the ability of silk to serve as a biopolymer for drug delivery as well as 
to assume various forms, including hydrogels (Seib and Kaplan 2013).  
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Figure 1 Overview of the different scales and hierarchical structure of silkworm and spider 
dragline silk fibres. (A) Both spider and silkworm silks are similar and are composed of 
numerous interlocking nano-fibrils. The b-sheet crystals stabilise the silk fibril and provides 
strength while and the amorphous segments within these nano-fibrils endow silk with elasticity.  
Each b-sheet crystal is composed of stacked sheets that are stabilised by hydrogen bonding 
between each sheet. The yellow box indicates the unit cell of a single b-sheet crystal. Atomic 
force microscopy image of the nano-fibrillar structure in B. mori silk (scale bar 100 nm). (B) 2 
dimensional schematic of B. mori silk. Numbers are aligned with the hydrophobicity pattern. (C) 
Model of B. mori heavy chain folding and micelle formation. (i) Hydrophobicity pattern of the 
heavy chain with (ii) possible chain folding and (iii) micelle assembly of silk in water. Micelle 
formation is based on the block copolymer configuration of silk with internal smaller hydrophilic 
domains to promote solubility in water and larger chain terminal hydrophilic blocks in contact 
with the continuous water phase. (Panel A reproduced with permission from (Xu, Gong et al. 
2014), panel B from (Ha, Gracz et al. 2005) and panel C modified from (Jin and Kaplan 2003)). 
 
The primary sequence of B. mori silk heavy chain resembles that of an amphiphilic block 
co-polymer, with hydrophobic blocks alternating with hydrophilic ones (Ha, Gracz et al. 2005, 
Yucel, Lovett et al. 2014) (Fig. 1c). This block co-polymer is flanked by hydrophilic C- and N-
termini composed of completely non-repeating amino acid residues. Specifically, the heavy chain 
has 12 long hydrophobic, ÒcrystallisableÓ blocks that are interspaced by 11 nearly identical, less 
repetitive and more hydrophilic ÒamorphousÓ blocks that have an anionic character; the result is 
an overall silk isoelectric point of approximately 4 (Fig. 1b). The crystallisable blocks are made 
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up of GX repeats and account for 94% of the silk heavy chain sequence (Zhou, Confalonieri et al. 
2001) (Fig. 1c). The hexa-amino acid sequence, GAGAGS, is the main component of the typical 
silk b-sheet crystal and is interspersed with small, irregular GAAS tetrapeptides and 60 residues 
containing GY (GY~GY) sequences (Ha, Gracz et al. 2005). These GAGAGS/GY~GY 
crystalline building blocks are usually composed of glycine (G), alanine (A), serine (S), and 
tyrosine (Y), while valine (V), threonine (T), isoleucine (I) and phenylalanine (F) are not major 
residue types but sometimes appear in GAGAGS/GY~GY blocks (Ha, Gracz et al. 2005).  
 
One silk heavy chain has 12 intramolecular antiparallel b-strands and 11 amorphous 
regions. The amorphous regions typically consist of 31 amino acid with sequence irregularity 
(GT~GT), but always contain proline residues that can act as major factors for changing the 
backbone direction (Fig. 1b). The crystalline and amorphous blocks in the silk heavy chain 
contribute significantly to the fibreÕs physical properties (Ha, Gracz et al. 2005). In particular, 
sequence motifs, such as poly alanine-glycine (polyAG) and polyalanine (polyA) (β sheetÐ
forming), GXX (31-helix), GXG (stiffness), and GPGXX (β spiral), are key components, and 
their relative positioning and arrangement are intimately tied to the overall material properties 
(Omenetto and Kaplan 2010).  
 
Manipulation of the crystal form and content allow fine-tuning of the physical properties of 
silk and subsequently affect its performance as a drug delivery system (Yucel, Lovett et al. 2014). 
In aqueous solutions, the crystallisable domains of silk form b-strands and 3-stranded b-sheets, 
which are stabilised through hydrogen bonding; the increasing interaction of the hydrophobic 
blocks drives b-sheet formation through lateral and facial packing (Ha, Gracz et al. 2005, Yucel, 
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Lovett et al. 2014). The hydrophobic, crystallisable blocks are interspaced by hydrophilic blocks 
and capped by N- and C-terminal sequences; this block copolymer arrangement drives the 
formation of 100Ð200 nm sized spherical micellar structures that contain a hydrophobic core of 
crystalline/amorphous domains, and a hydrophilic shell of the terminal domains (Jin and Kaplan 
2003) (Fig. 1c). These micelles remain loosely assembled, and the assembly process is reversible 
(Lu, Zhu et al. 2012).  
 
Under aqueous conditions that mimic the B. mori silk gland microenvironment, these 
nanometre-sized micelles assemble into larger microscale globules (0.8Ð15 µm) and gel-like 
states, while maintaining solubility (Werner and Meinel 2015). However, a number of external 
triggers, such as stretching, shearing, electromagnetic fields, solution concentration, pH and ionic 
strength cause irreversible physical intermicellar and inter globular crosslinking (Werner and 
Meinel 2015). The resulting silk networks have an increased b-sheet content and are formed 
though the self-assembly process detailed above, thereby eliminating the need for use of any 
harsh chemicals or crosslinkers. The self-assembly of silk into these globular micelles is exploited 
when generating silk nanoparticles (Werner and Meinel 2015); for example, the addition of an 
aqueous silk solution to a miscible organic solvent (e.g. acetone) results in nanoprecipitation and 
formation of nanoparticles (Seib, Jones et al. 2013) that are characterised by high crystallinity in 
the densely packed core (reviewed in (Zhao, Li et al. 2015)). 
 
The silk heavy chain shows crystalline polymorphism with three predominant forms, 
namely silk I, II and III (Marsh, Corey et al. 1955, Valluzzi, Gido et al. 1999, Asakura, Suzuki et 
al. 2013). Silk I is the metastable silk form present in silk solutions (Asakura, Suzuki et al. 2013); 
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it is characterised by intra- and intermolecular bonding repeats of type II and a b-turn structure 
that result in a more compact silk conformation than seen with silk II (Asakura, Suzuki et al. 
2013). Silk II represents the antiparallel b-sheets of crystallised silk that are found in spun silk 
fibres (Marsh, Corey et al. 1955, Asakura, Suzuki et al. 2013); silk III forms a 3-fold extended 
helix at a water-air interface (Valluzzi, Gido et al. 1999). Silk-based drug delivery devices are 
typically made up of a mixture of β-sheets, β-turns, helices and random coils, although the extent 
of each can be fined tuned, and this is known to influence drug release (Seib and Kaplan 2013, 
Yucel, Lovett et al. 2014).   
 
Spider Silks 
To date, B. mori silk cocoons are the most commonly used silk source for the development of 
drug delivery systems because B. mori silk can be readily mass-produced using sericultures (Seib 
and Kaplan 2013). In contrast, spiders cannot be farmed; therefore, spider silks are typically 
obtained by expression using a heterologous host via genetic engineering (Chung, Kim et al. 
2012). Dragline spider silk is the most commonly studied spider silk because this silk is used to 
build the frames and radii of orb webs, as well as serving as the spiderÕs safety line (Vollrath and 
Porter 2009, Porter, Guan et al. 2013). This silk is thus endowed with an exceptionally high 
tensile strength and elasticity to serve its function. Dragline silk is composed of two major 
proteins: the major ampullate spidroin 1 and 2 (MaSp1 and MaSp2) in silk from the Gold Orb 
weaver spider (Nephila clavipes) and Araneus diadematus fibroin 3 and 4 (ADF-3 and -4) in silk 
from the common European garden spider (Scheibel 2004).  The small peptide motifs of spider 
silks can be grouped into four major categories: (i) crystalline b-sheet rich poly(A)/poly(GA) 
motifs  (ii) helix forming GGX repeats, (iii) an elastic b-turn-like proline-rich region, composed 
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of multiple GPGXX motifs (where P is proline and X is mostly glutamine) and (iv) a spacer 
region with currently unknown functions (Tokareva, Jacobsen et al. 2014).   
 
Across all araneid, the dragline spider silks have a very high molecular weight (reviewed in 
(Scheibel 2004). For example, MaSP 1 and 2 silk proteins possess similar motifs and are 
approximately 3,500 amino acids long, resulting in a protein with a molecular mass of 250Ð350 
kDa (Sponner, Schlott et al. 2005, Ayoub, Garb et al. 2007). As is the case with B. mori silk, 
spider silks contain long repetitive sequences that are rich in glycine and alanine and are flanked 
at the C and N termini by non-repeating amino acid sequences approximately 100 amino acids in 
length (Ayoub, Garb et al. 2007); these non-repeating sequences are thought to orchestrate the 
self-assembly process during spinning (Jin and Kaplan 2003, Exler, Hummerich et al. 2007, 
Askarieh, Hedhammar et al. 2010, Hagn, Eisoldt et al. 2010). Analogous to the situation with B. 
mori silk, the polyalanine residues give high tensile strength to the silk fibre. These hydrophobic 
polyalanine blocks are typically made up of six to nine alanines and several polyalanine chains 
are required to form the crystalline β-sheet stacks. The glycine-rich motifs, such as GGX or 
GPGXX, adopt flexible helical structures and act as molecular springs interspersed among the 
crystalline regions to provide elasticity to the silk thread (Chung, Kim et al. 2012, Tokareva, 
Jacobsen et al. 2014).   
 
Unlike B. mori, which can be raised as sericultures, spiders are more challenging to raise 
for silk production and are rarely used as a primary silk source. The large size of naturally 
occurring spider silks and the highly repetitive nature of these proteins also pose challenges 
during expression in heterologous hosts, in part due to the limits of the glycyl-tRNA pools in the 
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expression host (Seib and Kaplan 2013). This has recently been overcome by the use of 
metabolically engineered E. coli, where recombinantly expressed silk matched the protein made 
by spiders with respect to its molecular weight and mechanical properties (Xia, Qian et al. 2010). 
However, most studies that have explored spider silks for drug delivery applications have used 
the ADF-4 and MaSp1 sequences to generate spider silk-inspired biopolymers that are tens of 
kDa in size. For example, eADF4-(C16) consists of 16 repeats of module C 
(GSSAAAAAAAASGPGGYG PENQGPSGPGGYGPGGP), which mimics the repetitive core 
sequence of ADF4 of the European garden spider and yields a biopolymer 48 kDa in size. This 
eADF4-(C16) biopolymer has been explored for various drug delivery applications, including silk 
nanoparticle (Lammel, Schwab et al. 2011) and hydrogels (Schacht, Jungst et al. 2015) for drug 
delivery. Recombinant silks have been the foundation for a number of spin out companies, 
including eADF4-(C16) which is central to AMSilkÕs commercial portfolio which now includes 
silk-based fibres, coatings and cosmetics.  
 
In addition to ADF4, the Nephila clavipes MaSp1 silk consensus repeat 
SGRGGLGGQGAGAAAAAGGAGQGGYGGLGSQGT has been widely studied for the 
generation of silk (nano)particles, fibres, hydrogels and hybrid materials for both tissue 
engineering applications and drug delivery (Tokareva, Jacobsen et al. 2014). The isolation of 
spider silk from the expression host will not be reviewed here (see excellent reviews; for 
example, (Scheibel 2004, Chung, Kim et al. 2012, Ebrahimi, Tokareva et al.). However, the 
extraction procedure used to isolate silk from cocoons has a significant impact on the final 
biopolymer properties, so this will be briefly reviewed. 
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Reverse Engineering Silk Cocoons 
Silkworm fibres consist of two types of proteins: silk fibroin (commonly referred to as silk) and 
sericins. Sericin is used by the worm during the spinning process to ÒglueÓ silk fibres together. 
Sericins are commonly removed when processing B. mori cocoons, as they are thought to induce 
an inflammatory response, especially in combination with silk (reviewed in (Altman, Diaz et al. 
2003)). Typical strategies for sericin removal include boiling (i.e. degumming) the cocoons in an 
aqueous alkaline solution (e.g. sodium carbonate) (Rockwood, Preda et al. 2011). While most 
studies report degumming times ranging from 20 to 60 minutes, a short 5 minute degumming 
process is usually sufficient to remove the sericin and minimise degradation of the silk. Silk is 
degraded into smaller fragments during prolonged boiling, which particularly affects the silk light 
chain, the disulphide bond between the light and heavy chain, and the amorphous regions in the 
silk heavy chain (Wray, Hu et al. 2011). After degumming, the extracted silk fibres can be used to 
generate yarns, sutures or woven fabrics. However, the generation of new silk material formats, 
such as silk hydrogels, typically requires that the extracted silk fibre be reverse engineered into an 
aqueous silk solution that resembles the silk dope found the silk wormÕs gland. Therefore, the silk 
fibre is dismantled with the use of chaotropic agents at elevated temperatures (e.g. 9.3 M LiBr at 
60¡C for up to 4 hours) to disrupt hydrogen bonding and unfold the silk crystalline domains.  
 
The resulting silk solution is dialysed extensively against water to yield an aqueous silk 
solution of typically 6% w/v. A more concentrated silk solution can be readily obtained by 
dialysing silk against a 10% w/v polyethylene glycol solution, which withdraws water from the 
silk preparation. The aqueous silk solution can be processed into various material formats, such as 
films, fibres, scaffolds, micro- and nanoparticles, as well as hydrogels (Rockwood, Preda et al. 
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2011) (Fig. 2). Irrespective of the silk format, the material needs to be suited for its intended use. 
In the following section, we will examine the rationale for using the silk biopolymer for drug and 
cell delivery. 
 
 
Figure 2 Diagram of silk sources and silk formats. Numbers in parentheses refer to the 
approximate sizes of these materials; diameters or thicknesses in the case of particles and 
films/coatings, respectively (reproduced with permission from (Seib and Kaplan 2013)) 
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Rationale for Using Silk for Drug and Cell Delivery 
A number principal attributes are typically cited in support of using silk for cell and drug 
delivery, including (i) biocompatibility, (ii) biodegradability, (iii) mild processing conditions, (iv) 
protection of the payload and (v) approved use in humans. Silk fibres are United States of 
America Food and Drug Administration (FDA) and European Medicines Authority (EMA) 
approved biomaterials for use in humans as medical sutures; silk-based surgical meshes have also 
received FDA/EMA approval. These meshes have been developed by Serica Technologies, Inc. 
Medford MA, USA (subsequently acquired in 2010 by Allergan, Inc.) using technology originally 
developed by David Kaplan and co-workers at Tufts University, MA, USA. Data from two 
clinical trials with these surgical meshes have been encouraging, with high levels of investigator 
and patient satisfaction scores and no adverse reactions due to the silk mesh (De Vita, Buccheri et 
al. 2014, Fine, Lehfeldt et al. 2015). Early phase trials are currently ongoing to test BioShield-S1 
silk coatings of silicone breast implants to improve hostÐtissue responses [based on eADF4(C16) 
spider silks manufactured by AMSilk, Munich, Germany]; these clinical studies were preceded by 
successful in vivo studies that showed no acute systemic toxicity and immunogenicity with 
eADF4(C16), as well as a significant reduction in capsule formation with the silk-coated silicon 
implants (Zeplin, Maksimovikj et al. 2014). In particular, the successful track record of silk 
sutures for use in humans has served as the launching platform for the development of silk-based 
materials for biomedical applications, including cell and drug delivery.  
 
Biocompatibility 
Nonetheless, the generic use of the term ÒbiocompatibilityÓ to describe silks is potentially 
misleading. In particular, the notion that any natural material automatically qualifies as 
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biocompatible is widespread but misleading, with potentially disastrous consequences. For 
example, some of the most toxic compounds known to man are of natural origin (e.g. botulinum 
toxin). When used clinically and for aesthetic purposes, both the dose and route of administration 
are critical for safe use. Therefore, all (bio)materials need careful assessment prior to their in vivo 
use. The biocompatibility definition by David Williams Òrefers to the ability to perform as a 
substrate that will support the appropriate cellular activity, including the facilitation of molecular 
and mechanical signalling systems, in order to optimise tissue regeneration, without eliciting any 
undesirable local or systemic responses in the eventual hostÓ (Williams 2008). Although silk has 
a proven track record in humans as a suture material, context specific biocompatibility assessment 
is still required when silk is being used beyond its licensed applications. For example, silk has 
been proposed for various vascular tissue engineering applications, but without first undergoing 
rigorous haematocompatibility assessment. We have assessed the blood compatibility of silk and 
were able to demonstrate a low haemostasis activity but an inflammatory response that was in 
part dependent on the processing history of the silk (Seib, Maitz et al. 2012, Seib, Herklotz et al. 
2014).  
 
Silk Biocompatibility 
In vivo studies in rats indicated that silk films implanted intramuscularly induced a mild 
inflammatory response, appearing in the form of fibroblasts, few new blood vessels and 
macrophages at the implant-host interface. This type of tissue response was more noticeable for 
polylactide and collagen films at 6 weeks post implantation than for silk films (Meinel, Hofmann 
et al. 2005). The silk scaffolds also showed different in vivo degradation behaviour depending on 
whether they were generated by water- or solvent-based processing. For example, water-based 
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silk scaffolds with large pore sizes (850Ð1,000 µm) were completely degraded and resorbed 
within 6 months, while solvent-based silk scaffolds with a similar pore size showed significantly 
less degradation over the same time course, with residual material still present one year after 
implantation. Throughout the study, the animals showed no visible signs of any adverse response. 
The low host immune response towards the implant was inferred by comparing mRNA 
expression of various markers, including interferon-g, tumour necrosis factor-α and interleukins, 
from the retrieved scaffolds and control tissues (Wang, Rudym et al. 2008). The results indicated 
that the macrophages recruited towards the silk were the main contributors to silk degradation, 
because only scaffolds that allowed cell infiltration showed any substantial degradation over the 
study period (Wang, Rudym et al. 2008). Silk has been reported to induce a transient and mild 
foreign body response that activates the complement system, but this response typically subsides 
within 14 days and does not progress to a chronic inflammatory response (Thurber, Omenetto et 
al. 2015).  
 
All biomaterials derived from a non-autologous source will elicit a foreign body response 
following implantation in vivo, albeit to varying degrees (Altman, Diaz et al. 2003). Historically, 
adverse reactions reported for silk sutures can be largely attributed to the use of virgin silk fibres 
that contained contaminating sericin, as this causes an allergic reaction, or to the use of braided 
silk fibres that were coated with waxes (commonly referred to as black braided silk) (Altman, 
Diaz et al. 2003). Silk fibroin elicits a foreign body response following implantation in vivo 
(Thurber, Omenetto et al. 2015), but this response is comparable to that elicited by the most 
popular synthetic materials in use today as biomaterials [e.g. poly(lactic-co-glycolic acid), 
polycaprolactone, polylactic acid].  
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The intensity of the biological response also depends on the implantation site and the 
model used for investigation. For example, silk scaffolds, films and hydrogels are commonly 
implanted subcutaneously (Thurber, Omenetto et al. 2015) and are expected to result in different 
biological responses when compared to that triggered by their placement into immune privileged 
sites such as the back of the eye (e.g. vitreous, retina), the testicles and, to some extent, the 
articular cartilage. A different biological response would be expected yet again following the 
administration of silk directly into tissues of the immune system, such as the spleen, lymph nodes 
or liver.  
 
Information is currently limited regarding the tissue response towards silk hydrogels, but 
the available data are encouraging (Etienne, Schneider et al. 2009, Critchfield, McCabe et al. 
2014, Hamilton, Shih et al. 2015). For example, injection of sonication-induced silk hydrogels 
into the cervix of pregnant rats (gestational day 13) as a potential therapeutic approach to preterm 
birth (Critchfield, McCabe et al. 2014, Brown, Partlow et al. 2016) resulted in a mild foreign 
body response similar to that observed with polyglycolic acid and poly(ethylene terephthalate) 
sutures (Critchfield, McCabe et al. 2014). These in vivo studies assessed the biological response 
at 4 days post treatment, and they were supplemented by in vitro studies with human cervical 
cells, which showed no up-regulation of inflammatory markers. However, the longer-term effects, 
such as longitudinal inflammatory responses, biodegradation or impacts on pregnancy (e.g. a shift 
to a post-term pregnancy), are currently unknown (Critchfield, McCabe et al. 2014).   
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One longer-term study compared silk hydrogels to collagen type I hydrogels both in vitro 
and in vivo (Etienne, Schneider et al. 2009). Nude mice, at one and two weeks post implantation 
of silk hydrogels, showed signs of inflammation in the tissues surrounding the silk hydrogels, as 
indicated by the presence of eosinophils, neutrophils and macrophages around the hydrogel 
periphery, but showed no infiltration of these cells within the hydrogel network. However, this 
silk-induced inflammatory response was less intense than that observed for collagen hydrogels, 
which attracted numerous neutrophils, eosinophils and macrophages that infiltrated the material 
and subsequently degraded the hydrogel completely within 4 weeks. At week 4, the inflammation 
around the silk hydrogel was greatly reduced and the hydrogel had cracks that were populated by 
spindle shaped cells; at 3 months, no inflammatory cells could be detected in or around the silk 
hydrogels, but vascularisation was apparent and the interstitial spaces were populated by stromal 
cells. Corroborating these observations are results from subcutaneously implanted 8% w/v silk 
hydrogels in rats, where significant hydrogel remodelling was initiated at 15 weeks post 
implantation, resulting in vascularisation, loss of hydrogel shape and degradation (Hamilton, Shih 
et al. 2015). 
 
Silk Biodegradation 
Most studies reporting the in vivo biodegradation of silk have assessed films and scaffolds; only a 
few studies have characterized silk hydrogels. One study used sonication-induced sol-gels that 
were preformed ex vivo and subsequently surgically implanted in mice. Cylindrically shaped 8 × 
6 mm silk hydrogels generated from a 4% w/v silk solution were subcutaneously implanted in 
nude mice and the biological response assessed over 12 weeks (Etienne, Schneider et al. 2009). 
At the endpoint of this study, fragmentation of the silk hydrogel was reported, although the 
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hydrogel maintained its shape and showed signs of vascularisation (Etienne, Schneider et al. 
2009). However, the exact extent of silk hydrogel degradation was not assessed as well as the 
process of vascularisation.  
 
Silk is biodegradable due to its susceptibility to proteases and enzyme-catalysed hydrolysis 
reactions. In particular, the disulphide bond between the light and heavy chains, as well as the 
amorphous silk sequences, are highly susceptible to degradation. In contrast, the crystalline 
regions are most resistant to proteolytic degradation due to reduced chain flexibility and access. 
Therefore, the b-sheet content has a protective effect on silk degradation both in vitro (Li, Ogiso 
et al. 2003, Horan, Antle et al. 2005, Meinel, Hofmann et al. 2005, Numata, Cebe et al. 2010, 
Brown, Lu et al. 2015) and in vivo (Meinel, Hofmann et al. 2005, Wang, Rudym et al. 2008). 
However, differences in packing geometries exist within the crystalline regions, ranging from 
tight to looser chain packing. This, in turn, results in differences in degradation behaviour; the 
tightly packed crystalline regions are made up of highly ordered b-sheets while the looser packing 
contains less ordered b-sheets as well as turn-and random-coil structures (Numata, Cebe et al. 
2010). In particular, the more loosely packed crystalline regions are susceptible to degradation 
and are degraded first.  
 
Protease XIV is a useful proteolytic model enzyme for uncovering some of the 
fundamentals of silk degradation over short study intervals (e.g. hours to days). For example, 
protease XIV studies showed that digestion of the more loosely packed b-sheets yielded 
nanofibrils around 4 nm thick and 80Ð100 nm wide that persisted over the course of the in vitro 
degradation study (24 h), as well as soluble silk fragments. Cytotoxicity studies indicated that 
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these protease XIV digested silk samples reduced cell viability (IC50 75 µg/ml), whereas disease-
associated b-sheets of amyloid b-peptide fibrils (IC50 20 µg/ml) were more cytotoxic (Numata, 
Cebe et al. 2010).  
 
At first sight, these observations might seem alarming, but a number of points need to be 
considered. First, no similar observations were made with silk that was degraded using a-
chymotrypsin to yield insoluble silk crystals and soluble hydrophilic domains; these showed no 
cytotoxicity at the maximum tested concentration (IC50 > 225 µg/ml), in sharp contrast to 
protease XIV degradation that generated soluble fragments with b-sheet structures (Numata, Cebe 
et al. 2010). Second, protease XIV is a non-mammalian enzyme; therefore, its degradation 
products are not necessarily encountered in vivo. Third, the degradation products generated by 
chymotrypsin, a mammalian enzyme, showed no cytotoxicity. Fourth, in vivo studies, and indeed 
observations in human clinical trials and during routine use of silk sutures, have not shown any 
overt adverse effects due to inadequate biodegradation. The US Pharmacopeia classifies silk 
sutures as non-resorbable. However, this is based on the definition that the material Òloses most 
of its tensile strength within 60 daysÓ post-implantation in vivo. Silk sutures significantly degrade 
within 1 year, and they are completely resorbed within 2 years (Altman, Diaz et al. 2003).   
 
In vitro studies and mapping of the silk primary sequence to a known protease cleavage site 
indicated that serine proteases (e.g. a-chymotrypsin, collagenase) and matrix metalloproteinases 
(MMPs) (MMP-1, interstitial collagenase, and MMP-2, gelatinase A) are particularly active in 
silk degradation (Brown, Lu et al. 2015). Our current understanding of silk degradation (Brown, 
Lu et al. 2015) and emerging evidence suggest that the amorphous regions of silk hydrogels are 
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degraded first. Thus, at an equivalent silk and b-sheet content, silk in hydrogel form is likely to be 
degraded fastest due to the open hydrogel frame structure, followed by porous scaffolds and 
films, where the monolithic structure restricts water ingress and thus hinders access of enzymes to 
the amorphous silk segments.  
 
Silk Hydrogel Manufacture 
Silk hydrogels can be broadly classified into physically (Ayub, Arai et al. 1993) and chemically 
crosslinked systems (Min, Nakamura et al.).  
 
Physically Crosslinked Silk Hydrogels 
A number of strategies have been explored to generate physically crosslinked silk hydrogels, 
including (i) ultrasound (Wang, Kluge et al. 2008), (ii) vortexing (Yucel, Cebe et al. 2009), (iii) 
CO2 acidification (Floren, Spilimbergo et al. 2012), (iv) non-solvent induced phase separation 
(Kasoju, Hawkins et al. 2016), (v) electrical fields (Leisk, Lo et al. 2010, Lu, Huang et al. 2011), 
(vi) temperature (Kim, Park et al. 2004) , vii) osmotic stress (Kim, Park et al. 2004, Ribeiro, de 
Moraes et al. 2014) and (viii) pH (Ayoub, Garb et al. 2007). The underlying basis of all these 
systems is the self-assembling behaviour of silk, which forms hydrogels due to the physical 
entanglements and hydrogen bonding between hydrophobic domains of the silk block copolymer. 
Under aqueous conditions, this self-assembly into micelles is a thermodynamic process, whose 
kinetics depend on molecular mobility, charge, hydrophilic interactions and concentration (Lu, 
Zhu et al. 2012). Therefore, any changes in these parameters due to the chosen processing 
technique will directly affect the final format of the silk.  
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Emerging evidence suggests that the silk I format is promoted by a high silk solution 
concentration (20% w/v) that causes the silk micelles to assemble initially into nanofilamentous 
structures. These silk I structures are metastable and do not involve changes in secondary 
structure, but they undergo weak hydrogen bonding as well as hydrophobic and electrostatic 
interactions (Matsumoto, Chen et al. 2006, Lu, Zhu et al. 2012). This initial stage is followed by 
changes to the secondary structure, including the formation of β-sheets (Matsumoto, Chen et al. 
2006), which give rise to strong intermolecular interactions and stabilise the silk hydrogel 
network, making the hydrogel structure essentially irreversible (Matsumoto, Chen et al. 2006). In 
contrast, low silk concentrations (1% w/v) promote the formation of silk micelles that transition 
directly into micellar aggregates (Lu, Zhu et al. 2012).  
 
Shearing of silk aqueous solutions (i.e. by vortexing, sonication, etc.) speeds up the self-
assembling kinetics and results in the formation of silk hydrogels within minutes to hours. These 
hydrogels transition from a random coil conformation to a β-sheet that contains some inter-chain 
physical crosslinks. In time, large numbers of inter-chain β-sheet crosslinks form and stabilise the 
overall structure (Wang, Kluge et al. 2008). The kinetics of this process can be further expedited 
by increasing the silk concentration, solution temperature, concentration of K
+
 ions, acidity (i.e. 
low pH) and energy input. However, excessive sonication leads to fragmentation of the silk fibres 
and negatively impacts hydrogel formation (Samal, Kaplan et al. 2013). 
 
The hydrogels that are produced by reducing the solution pH to a value close to the silk 
isoelectric point (pH 4.2) are characterized by extensive β-sheets (Ayub, Arai et al. 1993). The 
responsiveness of silk to pH is governed by its amphiphilic nature, due to the presence of large 
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hydrophobic blocks interspersed with hydrophilic amorphous regions, and due to its hydrophilic 
C- and N-termini. The N-terminus of the silk heavy chain is acidic (isoelectric point 4.6) and the 
C-terminus is basic (isoelectric point 10.5) whereas the C-terminus of the light chain is acidic 
(isoelectric point 5.1) (Kapoor and Kundu 2016). The acidic groups become protonated at low 
pH, leading to a reduced charge-charge repulsion that subsequently allows silk to adopt a more 
ordered state, with the formation of β-sheets that exclude water (He, Zhang et al. 2012).  
 
The use of high pressure CO2 during silk hydrogel manufacture acidifies the silk solution 
while changing the hydration shell and increasing the propensity for reduced volume states of 
silk. At high pressure, CO2 generates carbonic acid and, according to HenryÕs law, this process is 
directly proportional to the applied pressure. Experimental and theoretical calculations have 
shown the occurrence of robust gelation within 2 hours, yielding silk hydrogels that were at least 
2 fold more robust mechanically than hydrogels generated using traditional pH approaches 
(Floren, Spilimbergo et al. 2012).  
 
Water exclusion and subsequent β-sheet formation have been proposed for silk hydrogels 
formed under osmotic stress, pH, increased temperature (Matsumoto, Chen et al. 2006) and non-
solvent induced phase separation (Kasoju, Hawkins et al. 2016). However, silk hydrogels 
generated using low electrical DC fields differ markedly from those formed by these other 
processes, as they are formed through electrogelation (and are therefore referred to as e-gels). 
They deposit on the positive electrode and their formation is completed within minutes (Leisk, Lo 
et al. 2010).  
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Figure 3 Silk e-gel processing, characterisation and structure. Scanning electron micrographs of 
different hydrogel morphologies derived from silk solution (i) of low and (ii) high concentration 
and (iii) silk e-gel.  Reproduced with permission from (Lu, Zhu et al. 2012)) 
 
The electrogelation process is based on local pH changes that occur due to water 
electrolysis. The local pH drops at the positive electrode to a value below the isoelectric point of 
silk, thereby enabling silk deposition on the electrode (Lu, Huang et al. 2011, Kojic, Panzer et al. 
2012). The formation of the silk hydrogel can be predicted by ion electrodiffusion (Kojic, Panzer 
et al. 2012).  
 
Analysis of the secondary structure of the silk in e-gels indicated a transition from a 
random coil conformation to a helical conformation, but no changes in β-sheet content (as 
typically seen for sonicated or vortexed silk hydrogels). Reversal of the electric field led to a 
dissociation of the silk hydrogel and subsequent formation at the new positive electrode; this 
process could undergo many repeat cycles (Leisk, Lo et al. 2010). High resolution imaging 
showed that these hydrogels were formed from nanometre sized silk micelles that were 
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metastable (Lu, Huang et al. 2011). In the presence of a weak electric field, these silk micelles 
formed larger spherical structures that ranged from nanometres to several micrometres in size. 
These particles were able to assemble into hydrogels because the negative surface charge of the 
silk particles was screened by the low pH in the vicinity of the positive electrode (Lu, Huang et 
al. 2011). Overall, silk e-gels have been proposed for a range of biomedical applications due to 
their ability to control silk hydrogel assembly and to trigger the release of silk particles upon 
charge reversal, and because of the excellent adhesive properties of these hydrogels (Leisk, Lo et 
al. 2010, Lu, Huang et al. 2011, Kojic, Panzer et al. 2012).   
 
Physically crosslinked silk hydrogels are particularly promising for drug delivery and 
biomedical applications because their formation does not rely on chemical crosslinking and 
therefore avoids the use of potentially harmful agents such as organic solvents, chemical initiators 
or UV irradiation. Residual chemicals can leach from chemically crosslinked hydrogels, while 
UV-based polymerisation techniques are incompatible with cell viability. Silk hydrogels formed 
by sonication and vortexing are particularly well suited for drug and cell delivery because the 
payload can be added after the silk treatment but prior to the onset of gelation (Seib and Kaplan 
2013). However, physically crosslinked silk hydrogels show limited elastic behaviour and plastic 
deformation occurs typically at strains greater than 10%.  
 
Most physically crosslinked silk hydrogels rely on β-sheet crystals to stabilise the hydrogel 
network, which results in brittleness that prevents long range displacements and culminates in 
low elastic behaviour. The e-gels are notable exceptions, as they have outstanding elastic 
properties and can withstand strains of up to 2,500%. Nevertheless, they require the use of an 
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electric current to generate the low pH; an approach that is not compatible with cells. Therefore, 
alternative silk hydrogels are being developed that show better elastic behaviour.  
 
Chemically Crosslinked Silk Hydrogels 
Chemically crosslinked silk hydrogels have been synthesised using a range of chemistries 
(Kapoor and Kundu 2016). For example, horseradish peroxidase has been used to crosslink the 
phenol groups in the tyrosine amino acids in the silk protein (Partlow, Hanna et al. 2014). This 
generated elastic silk hydrogels that could withstand a shear strain of 100% and a compressive 
strain greater than 70%. The stiffness of these silk hydrogels could be fine tuned to range from 
200 to 10,000 Pa by adjusting the silk degumming times between 60 and 10 minutes, 
respectively. These crosslinked silk hydrogels are optically clear over the visible wavelength 
spectrum (Partlow, Hanna et al. 2014), making them different from physically crosslinked gels 
that typically contain nanocrystalline regions that scatter light. Horseradish peroxidase 
crosslinked silk hydrogels have subsequently been exposed to low-energy ultrafast laser pulses to 
generate complex 3D patterns within the hydrogels that could subsequently be populated with 
cells (Applegate, Coburn et al. 2015). Riboflavin, a photoactive crosslinker, has recently been 
used to generate in situ crosslinked silk corneal prostheses with the aim of improving visual 
acuity (Applegate, Partlow et al. 2016).  
  
Examples of Silk Hydrogels for Cell and Drug Delivery 
Silk hydrogels have been studied for a broad range of biomedical applications, including cell and 
drug delivery. For example, self-assembling silk hydrogels were developed for breast cancer focal 
therapy (Seib, Pritchard et al. 2013). Sonication-induced hydrogels were drug loaded prior to the 
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onset of gelation and drug release was subsequently assessed in vitro. Drug release was not 
affected by the silk degumming time, but doxorubicin release from these hydrogels was 
significantly affected by the weight percentage of the silk. Hydrogels with the lowest silk content 
released the drug fastest (27% cumulative drug release over 30 days), whereas the hydrogels with 
the highest amount of silk had the slowest drug release (17% cumulative drug release over 30 
days) (Seib, Pritchard et al. 2013). Injection of drug loaded silk hydrogels in close proximity to 
well-established orthotopic breast tumours, followed by in vivo monitoring and necropsy, showed 
that these hydrogels were well tolerated in biological systems. Complete tumour regression was 
observed in two of five animals investigated, and breast cancer metastasis was reduced when 
compared to animals administered an equivalent amount of doxorubicin by bolus intravenous 
injection (Seib, Pritchard et al. 2013). 
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Figure 4 Self-assembling silk hydrogels for focal breast cancer focal therapy. (A) Impact of 
processing parameters on the sol-gel kinetics of silk. (B) Silk hydrogels show no swelling post 
sol-gel transition. (C) Silk hydrogels can be readily loaded with drug; here, doxorubicin was 
added prior to the onset of gelation. (D) Injectability of drug loaded silk hydrogels. (E) Response 
of human breast cancer xenografts to treatment. Bioluminescence imaging of primary breast 
tumours at the end of the study and extent of metastasis. (Reproduced with permission from 
(Seib, Pritchard et al. 2013)) 
 
Sonication-induced silk hydrogels have also been used for ocular drug delivery of an 
antivascular endothelial growth factor (bevacizumab) (Lovett, Wang et al. 2015). In vitro drug 
release from 2% w/v silk hydrogels loaded with 5.0 mg of bevacizumab revealed a controlled 
drug release over 90 days for both doses. By contrast, the control drug formulation, Avastin, was 
eliminated form the test system within 30 days. The hydrogels showed an initial burst release (up 
to day 10) and a similar release profile to Avastin between days 11 and 20, but then showed a 
sustained zero order drug release over the remaining 60 days of the study. By contrast, drug 
release was exhausted for the Avastin control group by day 30. Pharmacokinetic assessment of 
the bevacizumab loaded silk hydrogels revealed an increase of two to three fold in the terminal 
elimination half-life in the vitreous and aqueous humour. In vivo biocompatibility studies 
indicated no overt adverse reactions due to the silk hydrogels over the course of the study, as 
verified by gross examination of the hydrogels, ophthalmic examination and fundus imaging. The 
silk hydrogels showed some signs of degradation from day 30 onwards, although the hydrogels 
(50 µl volume) were still present at the end of the study (day 90) (Lovett, Wang et al. 2015).  
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Physically crosslinked silk hydrogels show shear thinning, making them well suited for 
injection. Silk also has a remarkable ability to stabilise therapeutic proteins, largely due to the 
nanocrystalline regions that perform several functions, including providing a buffering capacity, 
tailoring water content at the nanoscale level and providing physical protection (reviewed in 
(Pritchard, Dennis et al. 2012)). Therefore, silk hydrogels serve as a delivery vehicle but they also 
provide active support for the payload. 
 
The excellent material properties of silk have supported the development of various 
hydrogel systems for soft and hard tissue engineering applications (Omenetto and Kaplan 2010). 
More recently, silk hydrogels have been assessed as a potential delivery system for pancreatic 
islet transplantation (Hamilton, Shih et al. 2015). Vortex induced silk hydrogels were generated 
and pancreatic islets were added prior to the onset of gelation and compared in vivo to pancreatic 
islet transplantations in the absence of silk. A third treatment group included silk hydrogel 
transplants that contained pancreatic islets and mesenchymal stem cells (MSCs). Diabetic mice 
regained glycaemic control, with the best control observed with the pancreatic islets and MSC 
silk hydrogels. However, histological assessment indicated that the MSCs had not only supported 
the graft but had also differentiated into bone and cartilage; an outcome that was not intended. 
Therefore, silk hydrogels not only served as a delivery vehicle but also mimicked the 
extracellular matrix (ECM) that stem cells sense and respond to (Hamilton, Shih et al. 2015). The 
viscoelastic properties of physically crosslinked silk hydrogels have received little attention to 
date, although emerging evidence indicates that rapid stress relaxation of viscoelastic hydrogels 
supports osteogenesis of MSCs (Chaudhuri, Gu et al. 2015). Indeed, ECMs found in vivo are 
viscoelastic; therefore, physically crosslinked silk hydrogels are well placed to serve as ECM 
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mimetics. However, these silk hydrogels are brittle, so alternatives to chemical crosslinking need 
to be explored. In this context, the inclusion of silk fibres has emerged as a valuable strategy 
(Yodmuang, McNamara et al. 2015), and silk fibre reinforced silk hydrogels have now been 
successfully used for the culture of chondrocytes. At day 40, these tissue engineered cartilage 
constructs closely resembled native tissue in both composition and physical performance 
(Yodmuang, McNamara et al. 2015).  
 
The spectrum of use of silk hydrogels goes beyond typical cell and drug delivery 
applications. For example, as part of the 3R initiative (i.e. replacement, refinement and reduction 
of animal experiments), silk-based brain dummies made from silk scaffolds and collagen type I 
hydrogels have been developed to study traumatic brain injury (Tang-Schomer, White et al. 
2014). These constructs faithfully recapitulate the brainÕs biophysical properties (Tang-Schomer, 
White et al. 2014) and, in future studies, could be used as a model system to study 
neurophysiology. Print technologies have been used to process both chemically modified B. mori 
silk solution (Suntivich, Drachuk et al. 2014) and recombinant spider silks (Schacht, Jungst et al. 
2015). The spider silks were used as aqueous solutions to encapsulate cells and were then allowed 
to undergo gelation. This mixture was subsequently extruded by application of pressure through 
an electromagnetically controlled valve. The resulting 3D constructs could be readily 
manufactured to a 500 µm resolution, and they supported cell viability. 
 
Summary and Outlook 
This chapter summarises recent developments in the production and use of silk-based hydrogels 
for cell and drug delivery. We have primarily focused on silk hydrogels, but have used other silk 
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formats for reference purposes, as a substantial body of work is available regarding silk particles, 
films and scaffolds for drug and cell delivery (Kasoju and Bora 2012, Seib and Kaplan 2013, 
Yucel, Lovett et al. 2014, Zhao, Li et al. 2015). This chapter has also omitted the development of 
silk ÒalloysÓ (e.g. recombinantly engineered silk elastins, reviewed in (Rnjak-Kovacina and 
Kaplan 2013, Price, Poursaid et al. 2014)) due to space constraints. Overall, silk is a truly 
remarkable biopolymer that will continue to amaze us. Clearly, at the time of this writing, silk is 
poised to change the way we deliver cells and drugs in the clinical setting.  
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